Stay updated with breaking news from Steven Deeks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Reports of two patients who found relief from long COVID after taking Pfizer's antiviral Paxlovid, including a researcher who tested it on herself, provide intriguing evidence for clinical trials to help those suffering from the debilitating condition, experts and advocates say.
Some researchers say Pfizer's COVID-19 oral antiviral treatment drug Paxlovid should be tested for effectiveness in treating 'long covid."
Research is showing that people who are vaccinated, even with just one dose, tend to have lower rates of long COVID-19 after catching the virus than those who are unvaccinated.
Though findings are preliminary, many studies suggest that vaccinated people have good protection against the condition, although just how much is still up for debate.
Though findings are preliminary, many studies suggest that vaccinated people have good protection against the condition, although just how much is still up for debate.